Adverum Biotechnologies
Stock Forecast, Prediction & Price Target
Adverum Biotechnologies Financial Estimates
Adverum Biotechnologies Revenue Estimates
Adverum Biotechnologies EBITDA Estimates
Adverum Biotechnologies Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $7.5M N/A | $0 -100% | $3.6M 0% | Avg: $7.69M Low: $7.69M High: $7.69M avg. 113.84% | Avg: $12.30M Low: $12.30M High: $12.30M avg. 59.79% | Avg: $20.10M Low: $20.10M High: $20.10M avg. 63.46% | Avg: $37.75M Low: $37.75M High: $37.75M avg. 87.73% |
Net Income
% change YoY
| $-145.54M N/A | $-154.53M -6.18% | $-117.16M 24.18% | Avg: $-141.73M Low: $-84.99M High: $-40.22M avg. -20.96% | Avg: $-167.44M Low: $-64.93M High: $-39.22M avg. -18.14% | Avg: $-52.75M Low: $-52.75M High: $-52.75M avg. 68.49% | Avg: $-41.26M Low: $-41.26M High: $-41.26M avg. 21.77% |
EBITDA
% change YoY
| $-141.47M N/A | $-150.60M -6.45% | $-112.59M 25.23% | Avg: $-1.53M Low: $-1.53M High: $-1.53M avg. 98.63% | Avg: $-2.46M Low: $-2.46M High: $-2.46M avg. -59.79% | Avg: $-4.02M Low: $-4.02M High: $-4.02M avg. -63.46% | Avg: $-7.54M Low: $-7.54M High: $-7.54M avg. -87.73% |
EPS
% change YoY
| -$14.85 N/A | -$15.57 -4.84% | -$11.62 25.36% | Avg: -$5.44 Low: -$8.43 High: -$3.99 avg. 53.19% | Avg: -$5.24 Low: -$6.44 High: -$3.89 avg. 3.65% | Avg: -$5.23 Low: -$5.23 High: -$5.23 avg. 0.15% | Avg: -$4.09 Low: -$4.09 High: -$4.09 avg. 21.77% |
Operating Expenses
% change YoY
| $153.62M N/A | $157.13M 2.28% | $127.59M -18.80% | Avg: $210.00M Low: $210.00M High: $210.00M avg. 64.58% | Avg: $335.57M Low: $335.57M High: $335.57M avg. 59.79% | Avg: $548.52M Low: $548.52M High: $548.52M avg. 63.46% | Avg: $1.02B Low: $1.02B High: $1.02B avg. 87.73% |
FAQ
What is Adverum Biotechnologies stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 12.79% in 2025-2028.
We have gathered data from 6 analysts. Their low estimate is -84.99M, average is -141.73M and high is -40.22M.
What is Adverum Biotechnologies stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 81.20% in 2025-2028.
We have gathered data from 4 analysts. Their low revenue estimate is $7.69M, average is $7.69M and high is $7.69M.
What is Adverum Biotechnologies stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 19.69% in 2025-2028.
We have gathered data from 6 analysts. Their low earnings per share estimate is -$8.43, average is -$5.44 and high is $-3.99.
What is the best performing analyst?
In the last twelve months analysts have been covering Adverum Biotechnologies stock. The most successful analyst is Luca Issi.